5-Me-MiPT
| Clinical data | |
|---|---|
| Other names | 5,N-Dimethyl-N-isopropyltryptamine; 5-Me-MiPT |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C15H22N2 |
| Molar mass | 230.355 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
5,N-Dimethyl-N-isopropyltryptamine (5-Me-MiPT) is a tryptamine derivative that is thought to be a psychedelic drug. It was first made in 1989. In vitro binding experiments on brain homogenates showed it to have serotonin receptor binding affinity between that of MiPT and 5-MeO-MiPT, both of which are known to be active psychedelics in humans.